Background {#s1}
==========

Human immunodeficiency virus (HIV) remains a noteworthy social issue worldwide in general and, in low- and middle-income nations specifically, where a considerable number of individuals living with HIV/AIDS (PLWHA) can be found. The WHO in 2017 reported that an estimated 36.7 million individuals were living with HIV infection and AIDS, with 2.1 million new cases and 1.1 million deaths as a result of HIV-associated causes ([@B1]).

Since 1990, HIV infection-associated death has reduced due to the introduction of active antiretroviral therapy (ART). Thus, people who are living with HIV/AIDS have begun to live longer. Nevertheless, people with HIV/AIDS are prone to mental illness, especially depression and anxiety, because of sexual-related problems, social and perceived stigma, the undesirable effects of antiretroviral treatment and neurophysiological changes ([@B2], [@B3]). Investigations indicated that as compared to HIV-negative individuals or the general population, depression occurs at rates two to four times higher in HIV-positive individuals ([@B4]--[@B9]). It has been observed to be related with higher HIV viral loads and lower CD4 number, even in the wake of controlling for the impacts of adherence, which predict illness advancement and mortality ([@B6], [@B10]--[@B12]).

Among psychiatric problems when compared with the general population, anxiety and depression are commonly found in HIV-affected people ([@B6]--[@B10]). Depression is a conceivably hazardous condition that can impact not just personal satisfaction, connections, work and adherence to therapeutic consideration, as well as possibly survival. The effect of mental health problems on HIV patients is frequently underestimated and is more critical in resource-constrained settings, which is due to an absence of training for health care providers, lack of awareness among HIV patients and lack of guidelines to manage psychiatric disorders in HIV clinics ([@B13], [@B14]).

People living with HIV/AIDS are increasingly inclined to display anxious and depressive symptoms which, thus, affects the stigma associated with the illness, decreases personal satisfaction, increases mortality, lessens medication adherence and impedes their capacity to resist disease ([@B13]--[@B16]). Having low income, being widowed, being female, having no job, substance abuse including alcohol, non-adherence to medication, low educational status and being in stage III and stage IV were factors that contribute to depression and anxiety among HIV patients ([@B17]--[@B19]). These show that anxiety and depression greatly affect these patient populations' treatment outcomes.

Therefore, this study aimed to assess the magnitude and correlates of depressive and anxious symptom among HIV patients in South Ethiopia.

Methods {#s2}
=======

**Study design and setting:** This research was undertaken as an institution-based cross-sectional study at Hawassa University Comprehensive Specialized Hospital (HUCSH) and Yirgalem General Hospital (YGH), South Ethiopia, from January 22, 2018 to March 22, 2018. HUCSH is the only comprehensive specialized university hospital in the region, and it is situated at Hawassa city, 273km from Addis Ababa, the capital of Ethiopia. This hospital started delivering service in 2004 and provides both outpatient and inpatient services for more than 18 million people in its catchment area. The hospital has over 400 beds for inpatient service. YGH is in the town of Yirgalem, which is 42km from Hawassa City and was established in 1966, delivers both inpatient and outpatient services to about 4.2 million people.

Sample size determination and sampling procedure**:** A single-population proportion formula was used to obtain the required sample size using a 95% confidence interval and a 5% margin of error using the prevalence of depression and anxiety: (larger proportion) proportion = 38.94% ([@B17]). Study participants were allocated to their respective study setting through a proportional allocation method. The study population was incorporated through a systematic sampling technique, K = 4. A total of 363 individuals with HIV who had follow-up for treatment were recruited for the study. The study participants who had hearing problems, patients who had known severe psychiatric illness or those who needed intensive care therapy were not interviewed.

**Data collection:** Experienced and trained psychiatry nurses gathered the data using interviewer-administered questioner. The data collection instrument incorporated socio-economic as well as demographic characteristics and clinically-related factors depicting questions. HIV-associated stigma was assessed through the 11-item HIV stigma scale. This scale comprised of four-point Likert questions concerning apparent isolation, shame, blame or guilt and disclosure of HIV status. The item scores of this scale questions summed to build a sole stigma variable. Study participants were classified as having or not having seen stigma utilizing the mean of the stigma scale (≥18.38 or ≥5.86) ([@B20], [@B21]). The Oslo 3-item social support scale was utilized to collect social support related issues. It has a total score scale running from 3 to 14 with three general classifications: "poor support" 3--8, "moderate support" 9--11 and "strong support" 12--14 ([@B22]). Anxious and depressive symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS). This is a 14-item questionnaire used to screen for manifestations of depression and anxiety symptoms. It was approved for local use in Ethiopia, and its internal consistency was 0.78 for anxiety, 0.76 for depression subscales and 0.87 for both scales. The scales utilize a cut-off point for anxiety and depression \>8 ([@B23]).

**Data Processing and Analyses:** The collected data was checked for comprehensiveness, consistency and, at that point data was coded, cleaned and entered into EPI info version 7. SPSS version 22 was utilized to examine the data. The association of every independent variable with the dependent variable was assessed by bivariate analysis. In order to distinguish potential confounders, a multi-variable logistic regression model was utilized. A p-value of under 0.05 was considered statistically significant, and adjusted odds ratio with 95% CI was determined to decide the association. Finally, the information was displayed by utilizing numbers, frequencies, tables, graphs and figures.

Results {#s3}
=======

Socio-Demographic Characteristics of the Study Participants {#s3_1}
-----------------------------------------------------------

A total of 363 study participants were selected for the investigation with a participation rate of 98.1%. The mean (±SD) age of the respondents was 37.66 years (±10.03). Among the investigation participants, 239 (65.8%) were females, 165 (45.5%) had primary school as their maximum level of education, 188 (51.8%) were married, 128 (35.3%) were merchants and 128 (35.3%) received less than 2500 Ethiopian birr per month (Table 1).

###### 

Socio-demographic characteristics of people living with HIV/AIDS at Hawassa University Comprehensive Specialized Hospital and Yirgalem Hospital, South Ethiopia, 2018.

  Characteristics            Category                   Frequency   Percent (%)
  -------------------------- -------------------------- ----------- -------------
  Sex                        Male                       124         34.2
  Female                     239                        65.8        
  Age                        18--29                     71          19.6
  30--39                     147                        40.5        
  40--49                     99                         27.3        
  ≥50                        46                         12.7        
  Residence                  Hawassa                    213         58.7
  Yirgalem                   150                        41.3        
  Religion                   Muslim                     54          14.9
  Orthodox                   155                        42.7        
  Protestant                 122                        33.6        
  Catholic                   32                         8.8         
  Educational level          Unable to write and read   49          13.5
  Primary school             165                        45.5        
  High school                100                        27.5        
  Tertiary education         49                         13.5        
  Marital status             Single                     67          18.5
  Married                    188                        51.8        
  Divorced                   55                         15.2        
  Widowed/widower            53                         14.6        
  Occupation status          Housewives                 65          17.9
  Civil servants             81                         22.3        
  Privet employee/NGO        30                         8.3         
  Day laborer                27                         7.4         
  Merchants                  128                        35.3        
  Unemployed                 32                         8.8         
  Monthly income             \<2500 ETB per month       266         73.3
  2500--5000 ETB per month   78                         21.5        
  \>5000 ETB per month       19                         5.2         

Clinical and Psychosocial Characteristics of the Study Participants {#s3_2}
-------------------------------------------------------------------

A total of 309 (85.1%) of the study participants were on ART, 154 (42.4%) had poor social support, 308 (84.8%) had CD4 cell count ranges between 200 and 1000, 220 (60.6%) had a child or children and 45 (12.4%) were currently using substances (alcohol and tobacco products) (Table 2).

###### 

Clinical and psychosocial characteristics of people living with HIV/AIDS at Hawassa University Comprehensive Specialized Hospital and Yirgalem Hospital, South Ethiopia, 2018.

  Variables                            Category                Frequency   Percent %
  ------------------------------------ ----------------------- ----------- -----------
  CD4 cell count                       \<200                   29          8.0
  200--1000                            308                     84.8        
  ≥1000                                26                      7.2         
  On ART                               Yes                     309         85.1
  No                                   54                      14.9        
  Perceived stigma                     No                      187         51.5
  Yes                                  176                     48.5        
  Current substance                    Yes                     45          12.4
  No                                   318                     87.6        
  Social support                       Poor social support     154         42.4
  Moderate social support              179                     49.3        
  Strong social support                30                      8.3         
  Family history of mental illness     Yes                     43          11.8
  No                                   320                     88.2        
  Previous history of mental illness   Yes                     23          6.3
  No                                   340                     93.7        
  Partner HIV status                   Sero-positive           201         55.4
  Sero-negative                        58                      16.0        
  Does not have partner                104                     28.7        
  Have child/children                  Yes                     220         60.6
  No                                   143                     39.4        
  Duration of illness                  \<5 years               11          30.6
  5--10 years                          183                     50.4        
  ≥10 years                            69                      19.0        
  Living status                        With Family/relatives   284         78.2
  Alone                                79                      21.8        
  Co-morbid medical Illness            TB                      38          10.5
  Diabetes                             19                      5.2         
  Heart Diseases                       16                      4.4         
  Renal diseases                       14                      3.9         
  No co-morbid illness                 276                     76.0        

Prevalence of Depressive and Anxiety Symptoms and Their Correlates {#s3_3}
------------------------------------------------------------------

The magnitude of co-occurring depression and anxiety in this study was 33.5%, while the prevalence of depression and anxiety was 32.0% and 34.4%, respectively. Multivariable binary logistic regression analysis revealed that HIV patients who had no children, were living alone, had perceived HIV related stigma and those who had poor social support were associated with depressive symptoms (Table 3). On the other hand, patients who had a previous history of psychiatric illness and poor social support were associated with anxiety symptoms (Table 4).

###### 

Factors associated with depression among people living with HIV/AIDS at Hawassa University Comprehensive Specialized Hospital and Yirgalem Hospital, South Ethiopia, 2018.

  Characteristics       Depression                 COR (95% CI)   AOR (95% CI)                                  
  --------------------- -------------------------- -------------- -------------------- ------------------------ -------------------------
  Sex                   Male                       90             34                   1                        1
  Female                157                        82             1.38, (0.86, 2.23)                            
  Age                   18--29                     46             25                   2.58, (1.04, 6.38)       
  30--39                91                         56             2.92, (1.27, 6.72)                            
  40--49                72                         27             1.78, (0.74, 4.30)                            
  ≥50                   38                         8              1                    1                        
  Educational level     Unable to read & write     30             19                   1.95, (0.82, 4.66)       
  Primary education     115                        50             1.34, (0.64, 2.78)                            
  Secondary education   65                         35             1.66, (0.77, 3.59)                            
  College and above     37                         12             1                    1                        
  Marital status        Single                     38             29                   1                        1
  Married               150                        38             0.33, (0.18, 0.61)                            
  Divorced              32                         23             0.46, (0.46, 1.94)                            
  Widowed/widower       27                         26             1.26, (0.61, 2.60)                            
  Children              Have children              164            56                   0.47, (0.30, 0.95)       0.53,(0.32, 1.16)
  Have no children      82                         59             1                    1                        
  Living status         With family or relatives   210            74                   1                        1
  Alone                 37                         42             3.22, (1.92, 5.39)   1.94, (1.06, 3.56)\*\*   
  Perceived stigma      Yes                        144            43                   2.37, (1.51, 3.74)       2.35, (1.44, 3.84)\*
  No                    103                        73             1                    1                        
  Social support        Poor                       89             65                   10.23, (2.35, 14.46)     5.57, (1.20, 10.84)\*\*
  Moderate              130                        49             5.28, (1.21, 9.89)   3.75, (0.82,10.24)       
  Strong                28                         2              1                    1                        

\*Significant association (p-value \< 0.05), \*\*significant association (p-value \< 0.01).

###### 

Factors associated with anxiety among people living with HIV/AIDS at Hawassa University Comprehensive Specialized Hospital and Yirgalem Hospital, South Ethiopia, 2018.

  Characteristics                           Anxiety         COR (95% CI)   AOR (95% CI)                                 
  ----------------------------------------- --------------- -------------- --------------------- ---------------------- -----------------------
  CD4 count                                 \<200           20             9                     0.64, (0.15, 2.84)     
  200--1000                                 198             110            0.79, (0.22, 2.88)                           
  ≥1000                                     20              6              1                     1                      
  Duration of illness                       \<5 years       76             35                    1                      1
  5--10 years                               120             63             1.14, (0.68, 1.88)                           
  ≥10 years                                 42              27             1.39, (0.74, 2.62)                           
  Partner HIV status                        Sero-positive   142            59                    0.43, (0.26, 0.71)     
  Sero-negative                             43              15             0.36, (0.18, 0.73)                           
  Don't have partner                        53              51             1                     1                      
  Perceived stigma                          No              124            63                    1                      1
  Yes                                       114             62             1.07, (0.69,1.65)                            
  Previous history of psychiatric illness   Yes             8              15                    3.92,(1.61, 9.53)      3.36, (1.31,8.61)\*
  No                                        230             110            1                     1                      
  Family history of mental illness          Yes             30             13                    0.81, (0.40, 1.61)     0.65, (0.44, 1.24)
  No                                        208             112            1                     1                      
  Social support                            Poor            83             71                    11.98, (2.76, 22.04)   6.67, (1.47, 10.33)\*
  Moderate                                  127             52             5.73, (1.32, 14.94)   3.83, (0.85, 8.23)     
  Strong                                    28              2              1                     1                      

\*Significant association (p-value \< 0.05).

Discussion {#s4}
==========

The prevalence of depression in the current study was in line with finding from South Africa ([@B24]). However, the current study finding was higher than other studies in Ghana, Nigeria, South Africa and Brazil ([@B18], [@B25]--[@B29]). On the other hand, it is lower than other studies in Ethiopia ([@B17], [@B26], [@B30]), in Delhi (India) ([@B19]), North Central Nigeria ([@B31]), in Cameroon 63% ([@B32]), USA, Denmark ([@B33], [@B34], China, India and Cameron ([@B35]--[@B37]). The prevalence of anxiety symptoms in the current study was 34.4%, which is similar with studies conducted in Ethiopia ([@B25]), USA, South Africa, Canada and Western Europe ([@B17], [@B37]--[@B39]). However, the finding was lower than studies conducted in Albania and China ([@B19], [@B27], [@B32]) but higher than studies conducted in Ethiopia, Ghana, Thailand, Brazil and Asia ([@B26], [@B38], [@B40]--[@B42]). This study used the hospital anxiety and depression scale (HADS) for assessing anxiety and depressive symptoms among HIV patients while others used the Hamilton depression scale (HDS), Beck's depression scale (BDS), Beck's anxiety scale (BAS), the State trait anxiety scale (STAS) or Patient health questionnaire item 9 (PHQ9). Socio-demographic and economic variation could play a vital role for the difference in the magnitude of depression and anxiety between studies from Ethiopia and other studies from other parts of the world.

Study participants who had HIV-related self-felt stigma had more depression when contrasted to their counterparts. This is in line with other findings in Botswana ([@B43]) and in Ethiopia ([@B17], [@B26], [@B30], [@B34]). HIV is associated with a large amount of stigma and, along these lines, HIV patients might think it is less demanding to be separated from everyone else in order to maintain a strategic distance from stigma or segregation, or they might not have the vitality to be socially connected ([@B30]--[@B34]). Stigma by itself might build dimensions of exhaustion and diminishing consideration or feelings of uselessness.

People living HIV/AIDS who were living alone were 1.94 times more prone to have depressive symptoms when contrasted to those HIV patients who were living with their family or relatives. Being forlorn is a solid hazard factor for depressive symptoms, well beyond proportions of target social interaction ([@B44], [@B45]).

Patients who had poor social support had a statically significant association with depressive and anxiety symptoms when contrasted to patients with good social support. This is comparable with other studies in India ([@B19]) and in Nigeria ([@B18], [@B19], [@B22], [@B26], [@B31], [@B32]). This may be because of the way that social separation diminishes social support, which can negatively affect mental and physical prosperity. Likewise, these patients preferred to abstain from looking for assistance from others and from opening up about their wellbeing because of social stigma towards themselves, which builds their seclusion and loneliness ([@B19], [@B26]).

Lastly, HIV patients with a past history of mental issues were 3.36 times more prone to experiencing anxiety symptoms. It is not clear whether the existence of HIV affects the seriousness of past psychiatric symptoms of patients or not. This may be because HIV by itself may cause progressively extreme symptoms. Moreover, HIV-affected patients with previous psychiatric problems presumably demonstrate a relapse of previous illness.

Conclusion {#s4_1}
----------

The magnitudes of depression and anxiety among HIV patients were high (32% and 34.4%, respectively). Perceived HIV-related stigma, living alone and poor social support had a significant association with depressive symptoms. Having a previous history of psychiatric illness and poor social support had a significant association with anxiety symptoms. Concerned health departments of the country should create principles and standards to screen and treat these conditions in this patient population. Further research on the hazards of anxiety and depression ought to be directed to reinforce and widen these findings

Study Limitations {#s4_2}
-----------------

We did not use standard tools or scales for substance abuse-related factors. Some important variables like medication adherence and opportunistic infections were not included.
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